Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aspire IRB
San Diego, CA, USA
- Ownership
- Private
- Employees
- ~15
- Development stage
- Other
01
Overview
Aspire IRB is a service provider that reviews, approves, and monitors clinical research involving human participants. The company has overseen over 1,000 Phase 0-IV clinical trials across diverse therapeutic areas including diabetes, cancer, multiple sclerosis, ALS, sleep disorders, depression, obesity, heart disease, and Alzheimer's disease. Aspire was the IRB of record for the first Phase 0 (microdosing) study.
- Industry
- Contract Research Organization
02
Partnerships
Beyond the preview
Go deeper on Aspire IRB.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aspire IRB.